Improving care for patients with interstitial lung disease using remote monitoring.
Remote Evaluation and Surveillance of Patients with Interstitial Lung Disease (RESPOND-ILD): Transforming ILD Care Delivery with Remote Monitoring
['FUNDING_OTHER'] · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · NIH-10949539
This study is looking at how a mix of in-person doctor visits and online check-ins can help people with interstitial lung disease (ILD) manage their condition better by using technology to keep track of their lung health.
Quick facts
| Phase | ['FUNDING_OTHER'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | UNIVERSITY OF CALIFORNIA, SAN FRANCISCO (nih funded) |
| Locations | 1 site (SAN FRANCISCO, UNITED STATES) |
| Trial ID | NIH-10949539 on ClinicalTrials.gov |
What this research studies
This research focuses on enhancing the management of interstitial lung disease (ILD) through a hybrid healthcare model that combines in-person visits with telehealth. By utilizing remote patient monitoring (RPM) technologies, such as spirometry and oximetry, the study aims to track disease progression and lung function more effectively. The approach leverages artificial intelligence to analyze RPM data, making it actionable for healthcare providers. This could lead to more timely interventions and better overall care for patients with ILD.
Who could benefit from this research
Good fit: Ideal candidates for this research are adults diagnosed with interstitial lung disease who require ongoing monitoring and management of their condition.
Not a fit: Patients with acute respiratory conditions or those not diagnosed with interstitial lung disease may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved monitoring and management of interstitial lung disease, resulting in better health outcomes for patients.
How similar studies have performed: Previous research has shown that remote monitoring can effectively track chronic diseases, indicating a promising potential for this approach in ILD management.
Where this research is happening
SAN FRANCISCO, UNITED STATES
- UNIVERSITY OF CALIFORNIA, SAN FRANCISCO — SAN FRANCISCO, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: FARRAND, ERICA DAVONNE — UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
- Study coordinator: FARRAND, ERICA DAVONNE
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.